Search for: "FOREST LABORATORIES, INC.," Results 141 - 160 of 161
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert Jacobsen v… [read post]
29 Jul 2008, 3:01 pm
., 4:06-md-01736 (RWS), a Multidistrict Litigation with approximately 42 cases alleging suicidal injuries caused by either Celexa or Lexapro, the defendants, Forest Laboratories, Inc. and Forest Pharmaceuticals, Inc. moved to dismiss 22 of the cases on conflict preemption grounds. [read post]
27 Jun 2008, 10:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
19 May 2008, 7:58 am
Forest Laboratories, Inc. v. candrug, WIPO Case No. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro (Escitalopram)… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
28 Mar 2008, 6:00 am
: (Patent Docs),US: Alnylam CEO forecasts ‘perfect storm’ for biomedical patents: (Patent Docs),US: Human Genome launches patent suit against Genentech over type of protein used to detect tumours: (IP Law360)Pharma & Biotech - ProductsCaduet (Atorvastatin/Amlodipine) – US: Pfizer sues Ranbaxy to block generic Caduet until 2016: (IP Law360),Dovonex (Calcipotriol) – Chancery Division EWHC grants interim injunction prohibiting Sandoz from distributing… [read post]
23 Mar 2008, 8:45 pm by GenericIPguy
New Litigation filings: Plaintiffs: Forest Laboratories, Inc., Forest Laboratories Holdings, Ltd., Merz Pharmaceuticals GmbH and Merz Pharma GmbH & Co. [read post]
23 Mar 2008, 7:52 pm
Forest Laboratories, Inc. et al. v. [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the generic… [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy': (IP… [read post]
2 Oct 2007, 3:44 am
"; in order for a licensee to have co-plaintiff standing, it must hold "at least some" of the proprietary rights under the patent; "[b]ecause the trial court erred by dismissing Mitutoyo's willful infringement claim and including HFTUSA's sales in the royalty base, but rendered a proper judgment in all other respects, we affirm-in-part, reverse-in-part, and remand"Forest Laboratories, Inc., et al. v. [read post]
13 Sep 2007, 12:45 am
., forest fires) from black carbon from burning of coal, the paper relies on non-sea-salt sulfur (nss-S). [read post]
5 Sep 2007, 8:38 pm
Noonan -- The Federal Circuit today affirmed a District Court finding that ANDA filer Ivax Pharmaceuticals and co-Defendant Cipla had not shown by clear and convincing evidence that Forest Laboratories' patent-in-suit for Lexapro ® was invalid. [read post]
5 Sep 2007, 3:50 pm
Forest Laboratories, Inc. v. [read post]